Illustration of pituitary gland with E-cadherin and NCAM protein representations

Pituitary Adenomas: What New Research on E-Cadherin and NCAM Means for You

Samir D’Costa monogram
Samir D’Costa in Health & Wellness October 2026 • 4 min read.

"Understanding the role of E-cadherin and NCAM markers in non-functioning pituitary adenomas for better treatment strategies."


Pituitary adenomas, while often benign and slow-growing, can present significant challenges due to their potential for local invasion. About 40% of these tumors exhibit this invasive behavior, making it crucial to understand the factors that influence their growth and spread. Current tumor markers don't always provide a clear picture, leading researchers to investigate new markers that could help predict and manage these tumors more effectively.

Recent studies have focused on E-cadherin and NCAM, two markers involved in cell adhesion. These markers play a vital role in how cells bind together, and changes in their expression might affect how pituitary adenomas grow and invade surrounding tissues. By studying these markers, scientists hope to gain a better understanding of the mechanisms driving tumor invasiveness.

This article breaks down the findings of a recent research paper that examines E-cadherin and NCAM in non-functioning pituitary adenomas (NFPA). We'll explore what these markers are, why they're important, and what the latest research suggests about their role in predicting tumor behavior. The aim is to make this complex information accessible and useful, providing insights that can help you better understand your condition and the ongoing efforts to improve treatment strategies.

AI Search Multiple angles on this topic

E-Cadherin and NCAM in Invasiveness

E-cadherin and neural cell adhesion molecule (NCAM) are proteins involved in cell adhesion. The ScienceDirect report states that altered expression of these markers can increase cellular mobility and may contribute to invasiveness in pituitary adenomas, although their precise role remains controversial. A 2019 review reports that E-cadherin and beta-catenin expression was significantly downregulated and associated with adenoma subtype, invasiveness, and postoperative recurrence.

Immunohistochemical Assessment

One established research approach is examining E-cadherin protein expression in somatotroph pituitary adenomas. The cited study evaluated this expression in relation to adenoma size, invasiveness, and the efficacy of somatostatin analog treatment. It also reported that nuclear translocation of E-cadherin correlated with pituitary tumor invasion, highlighting that cellular localization may matter in addition to overall expression.

E-Cadherin and NCAM: The Basics You Need to Know

Illustration of pituitary gland with E-cadherin and NCAM protein representations

E-cadherin and NCAM are proteins that play crucial roles in cell adhesion, which is how cells stick together to form tissues. Think of them as the 'glue' that holds cells in place. E-cadherin, or epithelial cadherin, is vital for maintaining the structure of epithelial cells, which line many organs and cavities in the body. NCAM, or neural cell adhesion molecule, is important in the development and function of the nervous system but also plays a role in other tissues.

In the context of pituitary adenomas, researchers are interested in how the expression of these proteins—the amount and activity of these 'glue' proteins—relates to tumor behavior. Changes in E-cadherin and NCAM levels could potentially influence how aggressively a tumor grows and whether it invades nearby tissues. Understanding these changes might offer clues for better predicting and managing the tumors.

  • E-Cadherin: Essential for cell structure and adhesion in epithelial tissues.
  • NCAM: Important for nerve cell function and also present in other tissues.
  • Relevance to Tumors: Changes in these proteins may indicate how aggressively a tumor will behave.
AI Search Multiple angles on this topic

Markers Under Current Investigation

Recent research has evaluated E-cadherin alongside Ki-67, CD-56, and Cyclin-D1 for associations with pituitary adenoma size, invasiveness, clinical presentation, and recurrence risk. A review reports that clinically significant pituitary adenomas occur in approximately one in every 1000 individuals, while craniopharyngiomas and pituicytomas are much less common. In a 2026 study of pituitary neuroendocrine tumor subtypes, low membranous E-cadherin expression was associated with higher odds of cavernous sinus invasion, with an adjusted odds ratio of 6.0 compared with higher expression and an adjusted odds ratio of 4.0 after accounting for tumor volume.

E-Cadherin and NCAM Compared

E-cadherin and NCAM are both cell-adhesion markers being studied in pituitary adenomas. The available source describes them as important for how cells bind together and reports that changes in their expression might affect tumor growth and invasion into surrounding tissues. Researchers are studying both markers to better understand the mechanisms that drive tumor invasiveness.

The study we're focusing on looked at tissue samples from 53 patients with non-functioning pituitary adenomas. The researchers used immunohistochemistry (IHC) and real-time PCR to assess the expression of E-cadherin and NCAM in these samples. IHC involves using antibodies to detect specific proteins in tissue sections, while real-time PCR measures the amount of gene expression, providing a more in-depth look at what’s happening at the molecular level.

What Does This Mean for Future Treatment Strategies?

While this study didn't find a direct link between E-cadherin and NCAM markers and the invasiveness of non-functioning pituitary adenomas, it's a valuable step forward. Research like this helps us refine our understanding of these tumors and search for markers that can help predict behavior. Continued exploration in this area will pave the way for more targeted, effective treatments.

AI Search Multiple angles on this topic

Invasion and Adhesion Signaling

A study of growth hormone-secreting pituitary adenomas examined E-cadherin, Slug, and NCAM expression in relation to the degree of tumor invasiveness. By assessing these three markers together, the research addressed adhesion-related and invasion-related features in this adenoma subtype. The study's focus illustrates the broader challenge of determining how marker expression patterns correspond to invasive behavior.

What the marker findings can and cannot establish

Taken together, these findings do not make E-cadherin accumulation a consistent indicator of invasion: an NFPT analysis found no association, and another comparison also found no significant expression difference between invasive and noninvasive adenomas. This leaves the marker's relationship with invasion unresolved across the reported cohorts.[1] [2]

Finding polysialylated NCAM more often in tumors selected as highly aggressive than in typical tumors is a contrast between groups, not proof that NCAM staining predicts invasion. Another report found no correlation between the staining pattern and invasive characteristics.[3] [4]

The reported link between E-cadherin and a more aggressive phenotype in epithelial cancers provides biological context, but it does not establish the same relationship in pituitary tumors.[5]

How methods and cohorts shape the comparisons

A cited study of adenomas with and without cavernous sinus invasion found no significant difference in E-cadherin expression between the groups. This is consistent with reports that did not find a direct association between E-cadherin accumulation and invasion in non-functioning tumors.[1] [2]

A technical difference can also affect comparisons: RT-PCR measures RNA without preserving tissue morphology, and RNA from non-tumor cells may contaminate tumor samples. That could contribute to discrepancies between molecular and tissue-based methods.[6]

What remains unresolved about marker interpretation

  • How much of the disagreement between RNA-based and tissue-based results reflects differences in what those methods capture, including possible non-tumor cell contamination?[6]
  • Does NCAM staining pattern track invasion in some settings, or do the contrasting group-level expression observations reflect differences in which tumors were examined?[3] [4]

Terms used in marker research

Epithelial tissue
Tissue in which E-cadherin is highly expressed[5]

Sources

  1. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features (2020)
  2. Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas. (pubmed.ncbi.nlm.nih.gov)
  3. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. (pubmed.ncbi.nlm.nih.gov)
  4. Neural cell adhesion molecule expression in human pituitary adenomas. (pubmed.ncbi.nlm.nih.gov)
  5. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours (pmc.ncbi.nlm.nih.gov)
  6. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What are E-cadherin and NCAM, and what do they do?

E-cadherin and NCAM are both proteins that are essential for cell adhesion. E-cadherin is specifically important for maintaining the structure of epithelial cells, which line many organs. NCAM plays a role in the nervous system and other tissues. They act like 'glue' to hold cells together, and changes in their expression can influence how a tumor grows and invades.

2

What are pituitary adenomas, and why are E-cadherin and NCAM important in this context?

Pituitary adenomas are tumors of the pituitary gland. They are often benign, but about 40% can exhibit invasive behavior. The significance of studying E-cadherin and NCAM in these tumors lies in understanding how these markers affect the tumor's aggressiveness and its ability to spread. Changes in the expression of these proteins may correlate with how aggressively a tumor grows and invades nearby tissues. Better understanding of these markers could help predict and manage these tumors more effectively.

3

How did the researchers study E-cadherin and NCAM in this research?

Immunohistochemistry (IHC) and real-time PCR are two techniques used in the research. IHC uses antibodies to detect specific proteins like E-cadherin and NCAM in tissue samples. Real-time PCR measures the amount of gene expression. These techniques provide scientists with in-depth information about the presence and activity of E-cadherin and NCAM within the tumor cells. The study utilized these to assess E-cadherin and NCAM expression in 53 patients.

4

What were the main findings regarding E-cadherin and NCAM?

The current study did not find a direct correlation between E-cadherin and NCAM markers and the invasiveness of non-functioning pituitary adenomas. However, it is a valuable step in understanding the role of these markers. It helps refine our understanding of these tumors and aids the search for markers that can help predict tumor behavior. The exploration of E-cadherin and NCAM is significant because it could potentially lead to more targeted, effective treatments.

5

Why were non-functioning pituitary adenomas (NFPA) the focus of this study?

Non-functioning pituitary adenomas (NFPA) are pituitary tumors that do not produce hormones. Although this study did not find a definitive link, the research focused on these adenomas because they often present challenges due to their potential for local invasion, making it important to understand the factors that influence tumor growth and spread. Understanding the behavior of NFPAs, including the role of E-cadherin and NCAM, is crucial for developing better treatment strategies.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.